Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210% % 37%
Quick Ratio 1.6% % -49%
Debt-to-equity 192% % -59%
Return On Equity 19% % -60%
Return On Assets 8.1% % -25%
Operating Margin 31% % 16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,968,350 shares 17%
Common Stock, Shares, Outstanding 7,086,670 shares 29%
Entity Public Float $524,000,000 USD 2779%
Common Stock, Value, Issued $7,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 6,361,427 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 6,756,108 shares 23%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $875,257,000 USD 82%
General and Administrative Expense $51,653,000 USD 23%
Costs and Expenses $430,976,000 USD 52%
Operating Income (Loss) $275,625,000 USD 111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $244,781,000 USD 123%
Income Tax Expense (Benefit) $64,424,000 USD 345%
Net Income (Loss) Attributable to Parent $70,789,000 USD 36%
Earnings Per Share, Basic 11.13 USD/shares 12%
Earnings Per Share, Diluted 10.48 USD/shares 13%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $185,574 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $62,745,336 USD 18%
Inventory, Net $2,866,000 USD 0.56%
Other Assets, Current $313,847,000 USD
Assets, Current $473,025,000 USD 315%
Deferred Income Tax Assets, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $26,955,000 USD -3.3%
Intangible Assets, Net (Excluding Goodwill) $21,230,000 USD 37%
Goodwill $13,919,000 USD 0%
Other Assets, Noncurrent $662,000 USD -6.9%
Assets $918,525,000 USD 40%
Accounts Payable, Current $19,836,000 USD 15%
Liabilities, Current $157,911,000 USD 2.4%
Deferred Income Tax Liabilities, Net $9,089,000 USD
Operating Lease, Liability, Noncurrent $30,037,000 USD -1.9%
Other Liabilities, Noncurrent $310,470,000 USD
Liabilities $495,088,000 USD 6.1%
Retained Earnings (Accumulated Deficit) $286,187,000 USD 20%
Stockholders' Equity Attributable to Parent $329,447,000 USD 149%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $423,437,000 USD 125%
Liabilities and Equity $918,525,000 USD 40%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $50,965,000 USD 1570%
Net Cash Provided by (Used in) Financing Activities $6,812,000 USD -220%
Net Cash Provided by (Used in) Investing Activities $64,000 USD 91%
Common Stock, Shares Authorized 950,000,000 shares 0%
Common Stock, Shares, Issued 7,086,670 shares 29%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $185,871,000 USD 357%
Interest Paid, Excluding Capitalized Interest, Operating Activities $608,000 USD 11%
Deferred Tax Assets, Valuation Allowance $0 USD -100%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 48%
Deferred Tax Assets, Gross $66,629,000 USD -11%
Payments to Acquire Property, Plant, and Equipment $64,000 USD -91%
Property, Plant and Equipment, Gross $126,277,000 USD 22%
Operating Lease, Liability, Current $2,152,000 USD 3.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 10%
Deferred Income Tax Expense (Benefit) $2,500,000 USD -2532%
Deferred Tax Assets, Operating Loss Carryforwards $0 USD
Additional Paid in Capital $615,627,000 USD 26%
Amortization of Intangible Assets $1,300,000 USD -13%
Depreciation, Depletion and Amortization $20,530,000 USD 8.2%
Share-based Payment Arrangement, Expense $15,942,000 USD
Interest Expense $17,622,142 USD 28%